Eigen RadarScience
Archive
Analysis

Apelin misses the urine-output target in a controlled human experiment

Apelin did not meaningfully increase urine output in fifteen healthy adults with experimentally induced water retention. The blinded crossover study compared two doses against placebo within the same volunteers. A planned patient stage consequently did not proceed. Changes in blood sodium warrant separate investigation, but secondary and post-hoc findings do not establish a treatment benefit for people with the actual syndrome.

Science··Night
A clear collection vessel with shallow yellow liquid on a steel trolley beside an IV stand and empty examination bed.

The main outcome stayed close to placebo

The experiment in Nature Communications compared apelin with placebo in fifteen healthy adults. Researchers first induced inappropriate water retention using desmopressin, drinking water and intravenous fluid. Each volunteer attended separate visits for the two doses and placebo, in randomized order. Neither volunteers nor investigators knew which infusion was being given, allowing responses within the same person to be compared.[1]

Each infusion lasted three hours. Across the four-hour primary measurement window, average urine volumes were 173 millilitres with placebo, 156 with the lower dose and 158 with the higher dose. Adjusted differences had confidence intervals spanning zero. The planned interim decision therefore stopped progression to a patient stage.[1]

A sodium signal needs a separate test

Blood sodium rose after the higher dose, prompting additional mechanistic questions. But secondary comparisons lacked adjustment for multiple testing, and some longer follow-up and sex comparisons were post-hoc. Increased urination did not explain the sodium change. These findings can guide another experiment without overturning the negative primary outcome.[1]

An induced model leaves patient benefit unresolved

This single peer-reviewed study used a small, short-lived model in healthy volunteers. Strong desmopressin activity may have constrained the hormone’s effects, but patients with the actual syndrome were not tested. The experiment establishes neither clinical benefit nor long-term safety for those patients; both require evidence beyond this setting.[1]

References

  1. News sourceNature CommunicationsApelin failed to increase urine output in an induced water-retention experiment↩1↩2↩3↩4
Space and explorationEnergy transition and climate

More analysis from this desk

View all Brief analyses from the Science desk →